ACI in Real Clear Policy: Progress on Biosimilars – Not Fast Enough ByAlan Daley July 31, 2014February 28, 2024
Making the Case for Biosimilars: ACI in the Hill’s Congressional Blog ByProf. Joseph Fuhr July 30, 2014July 30, 2014
FDA Orders a Company to Shutdown: And What Exactly is the Consumer Benefit? ByZack Christenson December 5, 2013
